Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations.

Alexander StahmannElaine CraigDavid EllenbergerFiras FneishNiklas Frahm Kathryn C Fitzgerald Rodden M MiddletonRichard NicholasJeff RodgersClemens WarnkeSalter Amber

Published in: Therapeutic advances in neurological disorders (2024)

Time to DMT initiation differs across the populations studied, indicating that barriers may exist in early access to DMT, particularly in the United Kingdom. However, a consistent decrease in time to DMT initiation was noted since 2017 across all registries. Further studies are warranted comparing the effects of time to DMT and time to higher-efficacy DMT on long-term outcome.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
stem cells
bone marrow
cell therapy